Genetics play an important role in the pathogenesis of hereditary colorectal cancer. Mutations in the APC (adenomatous polyposis coli) gene gives rise to familial adenomatous polyposis (FAP), while mutations in the mismatch repair (MMR) genes cause hereditary non-polyposis colorectal cancer (HNPCC) 3 . HNPCC may be associated with mutations in any one of 5 MMR genes. The majority of patients with HNPCC have mutations in the MLH1, MSH2 and MSH6 genes. Laboratory investigations to determine the presence of MMR gene mutations or the stability of microsatellites in colorectal cancers are laborious and expensive. Antibodies to MLH1, MSH2 and MSH6 proteins are available for use in immunohistochemistry (IHC) and Koh et al 4 took the first step in investigating if this is a viable screening method locally. The histological sections of 80 young colorectal cancer patients were stained for MLH1, MSH2 and MSH6 and 18 (23%) were found to have deficient expression of one or more of these MMR products. However, the MLH1 may be absent because of methylation of the promoter rather than because of a germline mutation of the MMR gene. This is especially with MLH1. While IHC will not tell us if the MMR protein is deficient because of a germline mutation or promoter methylation, this may prove to be an important screening method to determine which cancers to subject to more expensive MMR gene mutations analysis. The next step would involve sequencing the MMR genes in these 80 cancers for mutations to determine the sensitivity and specificity of IHC for MLH1, MSH2 and MSH6.
The vast majority of colorectal cancers are diagnosed at endoscopy. Endoscopy is also used to screen for colorectal cancer and polyps and remove colonic polyps 5 . Advances in endoscopic technology has seen the introduction of a whole slew of endoscopes with image enhancing functions 6 . High definition endoscopes, endoscopes with digital chromoendoscopic abilities (narrow band imaging, FICE, i-Scan), autofluorescence, and confocal endomicroscopic functions are now available. Two of these new endoscopic features, narrow band imaging and autofluorescence, are reviewed by Thia et al 7 in this issue. These new features permit the endoscopist to examine the lesions found in greater detail. However, it is uncertain if the current generation of image enhanced endoscopes can produce images that can replace histological sections. While there are currently no Singapore recommendations for the use of image enhanced endoscopes for colorectal cancer screening, endoscopes with these new features have gradually made their way into the endoscopy suites of local hospitals. We may soon Proceedings of Singapore Healthcare  Volume 19  Number 1  2010 see papers describing our own experience in the use of these new endoscopes in the literature.
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